Prostate Cancer Clinical Trials in Toronto, Ontario

48 recruitingToronto, Ontario, Canada

Showing 120 of 48 trials

Recruiting
Phase 3

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 1

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Advanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression
Bayer198 enrolled35 locationsNCT06217822
Recruiting
Phase 3

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC1,314 enrolled324 locationsNCT06136650
Recruiting
Not Applicable

WATER IV Prostate Cancer

Localized Prostate Cancer
PROCEPT BioRobotics280 enrolled37 locationsNCT06651632
Recruiting
Phase 3

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Prostate Cancer
Canadian Cancer Trials Group710 enrolled57 locationsNCT06235697
Recruiting
Phase 3

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Prostate Cancer Metastatic
Merck Sharp & Dohme LLC1,310 enrolled282 locationsNCT06136624
Recruiting
Phase 3

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Metastatic Castration-Sensitive Prostate Cancer
AstraZeneca1,800 enrolled410 locationsNCT06120491
Recruiting
Not Applicable

Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program

Prostate Cancer
Gabriela Ilie2,130 enrolled16 locationsNCT04895839
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Phase 2

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Stage IVB Prostate Cancer AJCC v8Prostate AdenocarcinomaOligometastatic Prostate Carcinoma+2 more
NRG Oncology194 enrolled239 locationsNCT05053152
Recruiting

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

Prostate CancerSurvivorshipSexual Dysfunction+6 more
University Health Network, Toronto575 enrolled10 locationsNCT06877598
Recruiting
Not Applicable

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

Lung CancersCancerColon Cancer+2 more
University of Calgary740 enrolled5 locationsNCT06960291
Recruiting
Not Applicable

Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer

Prostate CancerCancer of ProstateProstate Adenocarcinoma
Sunnybrook Health Sciences Centre144 enrolled1 locationNCT05600400
Recruiting
Phase 2

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

OligoProgressive Metastatic DiseaseCastrate Resistance Prostate Cancer
University Health Network, Toronto75 enrolled1 locationNCT06927635
Recruiting
Not Applicable

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

Prostate CancerProstate Cancer Recurrent
University Health Network, Toronto20 enrolled1 locationNCT06508567
Recruiting
Not Applicable

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Prostate CancerCardiovascular Disease
McMaster University6,000 enrolled54 locationsNCT03127631
Recruiting
Phase 2

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Prostate Cancer
University of British Columbia315 enrolled9 locationsNCT04812366
Recruiting
Not Applicable

Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process

Breast CancerProstate Cancer
University Health Network, Toronto124 enrolled1 locationNCT06274892
Recruiting
Phase 2Phase 3

2 Ablative RadioTherapy Treatments for Prostate Cancer

Prostate Cancer
Sunnybrook Health Sciences Centre30 enrolled1 locationNCT04654338
Recruiting
Not Applicable

SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer

Prostate Cancer
Dr. Gerard Morton55 enrolled1 locationNCT04861415